Filing Details

Accession Number:
0000899243-18-009028
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-04-02 13:02:06
Reporting Period:
2018-03-28
Accepted Time:
2018-04-02 13:02:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314102 Eyepoint Pharmaceuticals Inc. PSDV Laboratory Analytical Instruments (3826) 262774444
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612343 Ew Healthcare Partners, L.p. 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No Yes No
1652285 Essex Woodlands Fund Ix-Gp, L.p. 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No Yes No
1652286 Essex Woodlands Ix, Llc 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No Yes No
1736240 Ew Healthcare Partners-A, L.p. 21 Waterway Avenue, Suite 225
The Woodlands TX 77380
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2018-03-28 8,273,461 $1.10 8,606,324 No 4 P Direct
Common Stock, $0.001 Par Value Acquisiton 2018-03-28 332,863 $1.10 8,606,324 No 4 P Indirect EW Healthcare Partners-A L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect EW Healthcare Partners-A L.P.
Footnotes
  1. Includes 8,273,461 shares held by EW Healthcare Partners L.P. ("EWHP") and 332,863 shares held by EW Healthcare Partners-A L.P. ("EWHP-A"). Essex Woodlands Fund IX-GP, L.P. ("Fund IX-GP") is the general partner of EWHP and EWHP-A, respectively. Essex Woodlands IX, LLC (the "General Partner") is the general partner of Fund IX-GP. The General Partner holds sole voting and dispositive power over the shares held by EWHP and EWHP-A. The managers of the General Partner are Martin P. Sutter, R. Scott Barry, Ronald Eastman (also a member of the Issuer's board of directors), Petri Vainio and Steve Wiggins (collectively, the "Managers"), and may exercise voting and investment control over the shares only by the majority action of the Managers.